Nirmacom generic Paxlovid, a COVID-19 oral medication developed by Hetero, has received WHO prequalification
According to the drugmaker’s press statement, this is the first prequalification for a generic version of Pfizer’s COVID-19 oral anti-viral medicine generic Paxlovid which the WHO has dubbed the best
